The low EPS estimate is $0.73, while the high EPS estimate is $0.98. Its share price has risen 25.79% in three months and is down -10.31% for the last five trades.
Bristol-Myers Squibb (NYSE:BMY) last posted its quarterly earnings data on Monday, February 5th. It has underperformed by 39.89% the S&P500. It should be noted that a moderate but negative weighted alpha indicates additional price decrease, though for not too long. (DLB) stake by 10.61% reported in 2017Q3 SEC filing. The objective of using RSI is to help the trader identify over sold and overbought price areas. The Altrinsic Global Advisors Llc holds 7,003 shares with $446,000 value, down from 357,595 last quarter. The stock increased 0.16% or $0.07 during the last trading session, reaching $45.08. It has underperformed by 16.38% the S&P500.
Other equities research analysts also recently issued research reports about the company.
Bristol-Myers Squibb (NYSE:BMY) pays an annual dividend of $1.60 with a yield of 2.70% and an average dividend growth of 2.70% based on a 3 Year Average. The biopharmaceutical company reported $0.74 earnings per share for the quarter, topping analysts' consensus estimates of $0.73 by $0.01. Leerink Swann maintained the stock with "Buy" rating in Thursday, July 27 report. Berenberg downgraded the stock to "Hold" rating in Thursday, August 11 report. Jefferies has "Buy" rating and $6300 target. UBS maintained the stock with "Buy" rating in Friday, August 19 report. The rating was maintained by Goldman Sachs on Thursday, August 10 with "Neutral". The company was maintained on Friday, April 29 by Barclays Capital. Zacks Investment Research lowered Bristol-Myers Squibb from a "hold" rating to a "sell" rating in a research report on Monday, January 29th. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has "Buy" rating given on Monday, October 30 by SunTrust. Jefferies maintained the stock with "Buy" rating in Monday, July 17 report.
Cardinal Health, Inc. Earnings Ahead: Quick Glance
Rival McKesson Corp also reported a quarterly profit above analysts' estimates last week, helped by its partnership with Walmart. The stock has actually weakened in the past week, as the company has gathered a -7.47% return in the past 5 trading days.
This represents an increase of 34% in the number of shares being shorted compared to the previous reading, and implies that investors felt more pessimistic about the stock during the past two weeks. Its down 0.22, from 1.26 in 2017Q2.
Want to see what other hedge funds are holding BMY? 137 funds opened positions while 460 raised stakes. CAPITAL WORLD INVESTORS owned.05% of Bristol-Myers Squibb Company (BMY) worth $2.01 billion at the end of the most recent reporting period.The investor is now holding 31,626,110 shares thanks to an increase of 17,001 new shares in their portfolio. (NASDAQ:CSCO). Wellcome Trust Limited (The) As Trustee Of The Wellcome Trust accumulated 6.80M shares. The shares price showing change of -0.52% so far this year and performed with flow of 20.05% during recent year. Finally, Dividend Assets Capital LLC purchased a new position in Bristol-Myers Squibb in the second quarter worth about $737,000. Godshalk Welsh Inc reported 4,550 shares stake. Vantage Advsr Ltd Llc, a Pennsylvania-based fund reported 5,846 shares. Ar Asset accumulated 1.51% or 59,924 shares. Excalibur Management Corp increased its holdings in Bristol-Myers Squibb by 2.1% in the second quarter. Roffman Miller Associate Pa holds 0.07% or 8,044 shares. The institutional investor held 94,336 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $6.01 million, up from 89,392 at the end of the previous reported quarter. Alpha Windward Limited Liability Com has 624 shares.
Since September 6, 2017, it had 1 buying transaction, and 2 sales for $646,385 activity. 4,000 Bristol-Myers Squibb Company (NYSE:BMY) shares with value of $249,187 were bought by Samuels Theodore R. II. Royal State Bank Of Canada stated it has 0.15% in Bristol-Myers Squibb Company (NYSE:BMY). Lynch Thomas J. Jr. sold $335,172 worth of stock or 5,300 shares.
Investors sentiment decreased to 1.04 in Q3 2017. Its down 0.16, from 1.18 in 2017Q2. It is positive, as 36 investors sold AOS shares while 132 reduced holdings. 107 funds opened positions while 619 raised stakes. The Manitoba - Canada-based Great West Life Assurance Can has invested 0% in Dolby Laboratories, Inc. Cypress Asset Management Tx holds 0.72% or 52,114 shares in its portfolio. (NYSE:DLB). Conestoga Cap Limited Com accumulated 6,293 shares. Invesco holds 14.79 million shares or 0.35% of its portfolio. (NYSE:DLB) or 656,112 shares. The Company's wealth management services and products include fixed income products, such as corporate credit products, real estate credit funds, factoring products, and mezzanine financing products linked to corporate merger and acquisitions and buyouts, and others; private equity products, such as investments in various private equity funds sponsored by domestic and worldwide asset/fund management firms, as well as real estate equity funds and private equity funds of funds; secondary market equity fund products; and insurance products, mutual funds, and other products. Miles Cap has invested 0.18% in Cisco Systems, Inc. (NYSE:DLB) for 26,617 shares. Murphy Cap Mngmt Inc owns 80,092 shares. (NYSE:DLB) for 774,397 shares. Public Employees Retirement Association Of Colorado invested in 4,688 shares. Merriman Wealth Mgmt reported 3,443 shares. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and eleven have given a buy rating to the company. Therefore 47% are positive. The firm has "Hold" rating by Jefferies given on Thursday, August 27. The stock of Dolby Laboratories, Inc. The rating was initiated by Atlantic Securities with "Underweight" on Friday, December 18.